[Non-cognitive symptom profiles in dementia--experience from psychiatric services and memory clinics].

Psychiatr Prax

Donauspital im Sozialmedizinischen Zentrum (SMZ) Ost Psychiatrische Abteilung und Memory-Clinic, Wien.

Published: March 1999

Objective: To assess the non-cognitive symptoms in 153 consecutive dementia patients admitted to our psychiatric ward or seen at the gerontopsychiatric ambulance and Memory Clinic.

Methods: We used the Global Deterioration Scale, the Hachinski Ischaemia Score, the Hamilton Psychiatric Rating Scale for Depression, and the Mini-Mental State Exam as staging tools in a cross-sectional design. A semi-quantitative 34-item questionnaire based on the Columbia University Scale for Psychopathology was employed to assess non-cognitive symptoms as reported by caregivers.

Results: All patients had disturbances of affect, 95% of behavior and 71% of motivation, while 52% and 29% had delusions and hallucinations, respectively. Delusions, but not hallucinations, were correlated with verbal and physical aggressiveness. Factor analysis extracted three complex variables which accounted for 40.6 percent of the observed total variance, and which were subsequently interpreted as manifestations of agitation, burdensome behavior, and depression. Using these variables, we then identified three categories of patients: Agitated, debilitated, and depressive-anxious. Depression and anxiety were most common 3-4 years after diagnosis. Patients with Alzheimer's disease had less severe behavioral and psychotic symptoms than those with other types of dementia. Agitation, depression, and loss of competence in daily living had a greater impact on caregivers than aggression and psychotic symptoms.

Conclusion: The non-cognitive symptom profile is related to the type of dementia, and shifts dynamically with disease progression.

Download full-text PDF

Source

Publication Analysis

Top Keywords

assess non-cognitive
8
non-cognitive symptoms
8
delusions hallucinations
8
[non-cognitive symptom
4
symptom profiles
4
profiles dementia--experience
4
dementia--experience psychiatric
4
psychiatric services
4
services memory
4
memory clinics]
4

Similar Publications

Secondhand smoke affects nearly 40% of children worldwide, leading to serious health and behavioral problems. Being neurotoxic, it poses potential risks for child health and learning. In Cuba, there is limited research on the association of secondhand smoke with children's brain health, especially in vulnerable populations like young children at home.

View Article and Find Full Text PDF

Mild cognitive impairment (MCI) is a state of objective cognitive decline that falls between normal aging and dementia, with a high prevalence among the elderly in China. Cognitive impairments in MCI patients involve multiple cognitive domains such as memory, language, attention, executive, visuospatial functions, and social cognition, as well as non-cognitive domains such as neuropsychiatric, mood, sleep, daily living activities, and frailty. The assessment and clinical diagnosis of MCI highly rely on neuropsychological testing.

View Article and Find Full Text PDF

Background: Mental health disorders are one of the leading causes of illness globally. The importance of psychosocial skills acquired in early childhood, such as executive functions, inhibitory control, emotional regulation, and social problem-solving, in preventing mental disorders has been reported. Furthermore, mental health care delivery is evolving, and mobile technology is becoming the medium for assessment and intervention.

View Article and Find Full Text PDF

Evaluating the Efficacy of Levetiracetam on Non-Cognitive Symptoms and Pathology in a Tau Mouse Model.

Biomedicines

December 2024

Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd, Tampa, FL 33612, USA.

Alzheimer's disease (AD) is marked by amyloid-β plaques and hyperphosphorylated tau neurofibrillary tangles (NFTs), leading to cognitive decline and debilitating non-cognitive symptoms. This study aimed to evaluate compounds from four different classes in a short-term (7-day) study using transgenic tau mice to assess their ability to reduce non-cognitive symptoms. The best candidate was then evaluated for longer exposure to assess non-cognitive symptoms, cognition, and pathology.

View Article and Find Full Text PDF

Plasma fibrinogen as a potential biomarker of cognitive impairment after acute ischemic stroke.

Sci Rep

December 2024

Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Jilin University, Changchun, China.

Fibrinogen (FBG) has been discovered to be associated with cognitive impairment (CI) and dementia. However, the exact correlation between FBG levels and CI after acute ischemic stroke (AIS) remains uncertain. Plasma FBG levels were measured in 398 patients with AIS who underwent comprehensive neuropsychological evaluation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!